Showing 811 - 820 of 831 for "Pharmaceutical" with applied filters
Filters:
31 July 2019 by Saya Choudhary Kapur and Vivek Ranjan
Saya Choudhary Kapur and Vivek Ranjan of Singh & Singh Law Firm examine the regulations surrounding medical devices in India and compare the law around patenting methods of treatment with that in the US and Europe
30 July 2019 by Kingsley Egbuonu
Four law firms were involved in the multi-billion dollar merger of Mylan and Upjohn, Pfizer’s off-patent branded and generics business
01 July 2019 by Kingsley Egbuonu
Some IP firms in Asia-Pacific and Europe announced promotions and appointments today
05 June 2019 by Alexander Robinson and Stephen Garner
Alexander Robinson and Stephen Garner of Mathys & Squire explore some of the regulatory issues in the life sciences and pharmaceutical sectors that are likely to be affected by Brexit
16 May 2019 by Paul A Ainsworth and Lauren A Watt
Paul A Ainsworth and Lauren A Watt of Sterne Kessler Goldstein & Fox examine the extent to which the proposed Biologic Patent Transparency Act will reduce patent thickets, increase transparency and competition in the biologics industry.
17 April 2019 by Kingsley Egbuonu
The firm strengthened its IP practice in New Jersey by hiring Andrew J Miller and his IP team
23 November 2018 by Ilya Kazi
Ilya Kazi and Miranda Kent of Mathys & Squire analyse the changes to the EPO’s opposition procedure and suggest ways in which businesses can align their strategy with the current legal tools available
01 September 2018 by Managing Intellectual Property
Resolution Chemicals v AstraZeneca B.V. and Shionogi (Supreme Court of The Netherlands, The Hague, June 8 2018) deals with the extent of the protection that is conferred by patent EP0521471 (EP 471), for rosuvastatin, a new cholesterol inhibitor.
01 September 2018 by Spoor & Fisher
On June 28 2018 the Zimbabwean authorities published a document entitled the Zimbabwe Intellectual Property Policy and Implementation Strategy.
01 September 2018 by Jing He
On June 1 2018, the Supreme People’s Court of China (SPC) issued the draft judicial interpretation on patent validity and examination cases for public comments
